United States · FDA National Drug Code directory
grisofulvin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-361_6cf78fd3-5be6-412c-acdf-f599efaf0654
- Product NDC
- 69097-361
- Form
- SUSPENSION
- Composition / generic term
- grisofulvin
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170306
- Source listing expiry
- 20261231
Source-listed ingredients
- GRISEOFULVIN — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE (69097-361-08) · 69097-361-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →